ADALIMUMAB-ADAZ

24063 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking ADALIMUMAB-ADAZ:

# Side effect Count
0 DRUG INEFFECTIVE 6513
1 OFF LABEL USE 3694
2 RHEUMATOID ARTHRITIS 2990
3 PAIN 2942
4 FATIGUE 2699
5 ARTHRALGIA 2631
6 DRUG INTOLERANCE 2314
7 TREATMENT FAILURE 2183
8 RASH 2017
9 CONDITION AGGRAVATED 1982
See all common reactions for ADALIMUMAB-ADAZ

ADALIMUMAB-ADAZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUPUS VULGARIS 131 0.6453
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 141 0.6078
2 RED BLOOD CELL SEDIMENTATION RATE 157 0.6062
3 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 162 0.5382
4 SYNOVIAL FLUID ANALYSIS 39 0.5000
5 PARADOXICAL PSORIASIS 70 0.3933
6 SWOLLEN JOINT COUNT INCREASED 444 0.3902
7 MUSCULOSKELETAL DEFORMITY 86 0.3805
8 RHEUMATIC FEVER 521 0.3399
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 172 0.3301
See all enriched reactions for ADALIMUMAB-ADAZ